Q4 2023 Aptose Biosciences Inc Earnings Call Transcript
Good afternoon. My name is Jonathan, and I will be your conference operator today. I would like to welcome everyone to Aptose Biosciences conference call for the fourth quarter and year ended December 31, 2023. (Operator Instructions) As a reminder, this conference call may be recorded. And now I'd like to introduce to your host for today's program Susan Pietropaolo. Please go ahead.
Thank you, Jonathan. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the fourth quarter and year ended December 31, 2023. Earlier today, Aptose issued a press release relating to the financial results. The news release as well as related SEC filings are accessible on Aptose's website.
Joining me on today's call are Dr. William Rice, Chairman, President, and CEO; Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer and Chief Business Officer.
Before we proceed, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
